Watchlist Price Alert

Maravai LifeSciences Inc... (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

2.17

0.01 (0.46%)

At close: Jun 17, 2025, 10:29 AM

Maravai LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-259.62M	-119.03M	490.66M	469.25M	78.82M	-5.2M	-16.91M
Depreciation & Amortization	56.87M	48.78M	38.1M	24.75M	25.84M	24.08M	22.35M
Stock-Based Compensation	49.41M	34.59M	18.67M	10.46M	24.63M	1.68M	2.12M
Other Working Capital	-28.07M	7.52M	-30.69M	-85.34M	86.96M	1.6M	-13.13M
Other Non-Cash Items	171.1M	-690.9M	-8.7M	-6.16M	-7.52M	2.42M	7.79M
Deferred Income Tax	2.32M	754.94M	42.32M	46.9M	-5.46M	-1.16M	317K
Change in Working Capital	-12.61M	97.84M	-45.08M	-176.63M	35.89M	2.29M	-15.84M
Operating Cash Flow	7.46M	126.22M	535.98M	368.57M	152.19M	24.11M	-186K
Capital Expenditures	-29.66M	-65.55M	-17.09M	-14.85M	-25.41M	-17.15M	-3.61M
Cash Acquisitions	n/a	-69.62M	-238.35M	119.96M	-3.02M	n/a	160K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	5.34M	12.87M	-12.17M	548K	34.5M	n/a	160K
Investing Cash Flow	-24.32M	-122.31M	-267.61M	105.66M	6.07M	-17.15M	-3.45M
Debt Repayment	-234.07M	-5.77M	-5.44M	-6M	196.92M	-2.64M	55.43M
Common Stock Repurchased	n/a	-20K	n/a	n/a	-1.46B	-227K	-9K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-52.06M
Other Financial Acitivies	-1.64M	-55.3M	-182.06M	-153.05M	-100.91M	-1.3M	-12.53M
Financial Cash Flow	-234.47M	-61.09M	-187.5M	-159.05M	53.21M	-4.17M	-9.17M
Net Cash Flow	-252.56M	-57.18M	80.87M	315.09M	211.48M	2.83M	-12.87M
Free Cash Flow	-22.19M	60.67M	518.89M	353.72M	126.78M	6.97M	-3.8M